Evidence map›Paper›PMID 32400009›Full record

ArticleThe EMBO journal2020

Mechanisms of site-specific dephosphorylation and kinase opposition imposed by PP2A regulatory subunits.

Thomas Kruse, Sebastian Peter Gnosa, Isha Nasa, Dimitriya Hristoforova Garvanska, Jamin B Hein, Hieu Nguyen, Jacob Samsøe-Petersen, Blanca Lopez-Mendez, Emil Peter Thrane Hertz, Jeanette Schwarz and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Phosphoproteome-derived peptide libraries for deep specificity profiling of phosphatases and phospholyases.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism.bioRxiv : the preprint server for biology · 2026
    Article
  6. Uncovering cancer dependencies in peptide-interacting protein pockets.bioRxiv : the preprint server for biology · 2026
    Article
  7. Decoding Cdk1 control: from mitotic thresholds to meiotic specificity.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Targeting PP2A in cancer: an underrated option.Journal of experimental & clinical cancer research : CR · 2025
    Review
  13. Review
  14. Houge-Janssens syndrome.European journal of human genetics : EJHG · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Thomas Kruse *Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2619-7388
Sebastian Peter Gnosa *Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
Isha Nasa *Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.
Dimitriya Hristoforova Garvanska *Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jamin B HeinNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hieu NguyenBiochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.
Jacob Samsøe-PetersenBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
Blanca Lopez-MendezNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Emil Peter Thrane HertzNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jeanette SchwarzBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
Hanna Sofia PenaBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
Denise NikodemusBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4492-817X
Marie KveiborgBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-1293-1019
Arminja N KettenbachBiochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.ORCID 0000-0003-3979-4576
Jakob NilssonNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4100-1125
University of Copenhagen · DKDartmouth College · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MADDEN, DEAN R · 2016 to 2025
$25.9M
Phosphorylation Signaling by Phosphoprotein PhosphatasesR35GM119455 · NIGMS · DARTMOUTH COLLEGE · PI Arminja Nadine Kettenbach · 2016 to 2026
$5.1M
LC-Orbitrap MS/MS System for shotgun Proteomics at DartmouthS10OD016212 · OD · DARTMOUTH COLLEGE · PI GERBER, SCOTT A. · 2013 to 2013
$600k
Independent Research Fund Denmark 7016 00086Independent Research Fund Denmark 8021-00101BKraeftens Bekaempelse (Danish Cancer Society) R146-A9211-16-S2Kraeftens Bekaempelse (Danish Cancer Society) R167-A10951-17-S2Marie Sklodowska Curie Grant 798716NCI NIH HHS P30 CA023108NIGMS NIH HHS P20 GM113132NIGMS NIH HHS R35 GM119455NIH HHS S10 OD016212Novo Nordisk Foundation NNF14CC0001Novo Nordisk Foundation NNF18OC0053124
6 · The paper itself

Abstract

PP2A is an essential protein phosphatase that regulates most cellular processes through the formation of holoenzymes containing distinct regulatory B-subunits. Only a limited number of PP2A-regulated phosphorylation sites are known. This hampers our understanding of the mechanisms of site-specific dephosphorylation and of its tumor suppressor functions. Here, we develop phosphoproteomic strategies for global substrate identification of PP2A-B56 and PP2A-B55 holoenzymes. Strikingly, we find that B-subunits directly affect the dephosphorylation site preference of the PP2A catalytic subunit, resulting in unique patterns of kinase opposition. For PP2A-B56, these patterns are further modulated by affinity and position of B56 binding motifs. Our screens identify phosphorylation sites in the cancer target ADAM17 that are regulated through a conserved B56 binding site. Binding of PP2A-B56 to ADAM17 protease decreases growth factor signaling and tumor development in mice. This work provides a roadmap for the identification of phosphatase substrates and reveals unexpected mechanisms governing PP2A dephosphorylation site specificity and tumor suppressor function.

Indexed as

ADAM17 ProteinAmino Acid MotifsAnimalsBinding SitesHeLa CellsHumansMicePhosphorylationProtein Phosphatase 2ADAM17 ProteinADAM17 protein, humanAdam17 protein, mousePP2A-B56alpha protein, humanProtein Phosphatase 2ADAM17phosphoproteomicsPP2Asubstrate specificitytumor suppressor

Identifiers

PMID32400009
PMCPMC7327492
OpenAlexW3024517740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.